HOLLY TROTTA: Open Payments
NPI 1346467495 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,109 in 108 payments from 19 companies in 2025. Trend: 2023 $1,324 · 2024 $2,974 · 2025 $2,109
Food & beverage: $2,098Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $371 |
| Janssen Biotech, Inc. | 14 | $261 |
| Phathom Pharmaceuticals, Inc. | 9 | $240 |
| Janssen Scientific Affairs, LLC | 4 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $195 |
| Regeneron Healthcare Solutions, Inc. | 7 | $158 |
| Gilead Sciences, Inc. | 6 | $129 |
| Aimmune Therapeutics, Inc. | 6 | $106 |
| Lilly USA, LLC | 5 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $96 |
Products named: TREMFYA, VOQUEZNA, RINVOQ, ENTYVIO, DUPIXENT, ZENPEP, OMVOH, LINZESS.
Industry payments across AR — which companies pay providers there.
